3B Blackbio Dx Limited (BOM:532067)
1,636.55
-15.90 (-0.96%)
At close: Jan 23, 2026
3B Blackbio Dx Company Description
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India.
The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs.
It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
3B Blackbio Dx Limited
| Country | India |
| Founded | 1972 |
| Industry | Agricultural Chemicals |
| Employees | 85 |
| CEO | Dhirendra Dubey |
Contact Details
Address: 7-C, Industrial Area Bhopal, 462023 India | |
| Phone | 91 75 5258 6536 |
| Website | 3bblackbio.com |
Stock Details
| Ticker Symbol | 532067 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dhirendra Dubey | Chief Executive Officer |
| Nikhil Dubey | Chief Financial Officer |